P2RX7 and lymphoma: Srivastava et al. (2018) demonstrated a good efficiency of the particles in reducing lymphoma burden and increasing overall survival of lymphoma-bearing mice, suggesting that this effect will be mediated by upregulation of P2X7 receptor and consequent cytotoxicity.